Market Overview

UPDATE: Bank of America Initiates Coverage on The Advisory Board Company on Rare Healthcare Growth Story

Related ABCO
Benzinga's Top Initiations
New Survey Gives J.P. Morgan Confidence To Go Overweight Athenahealth, Allscripts & Advisory Board

In a report published Friday, Bank of America analyst Robert M. Willoughby initiated coverage on The Advisory Board Company (NASDAQ: ABCO) with a Buy rating and $67.00 price target.

In the report, Bank of America noted, “Medicare/Medicaid entitlement cuts, changing payment models, and health care reform uncertainties are contributing to an increasingly complex health care environment, but these industry dynamics are a boon for ABCO, which helps providers execute operationally and strategically. It plans to grow by cross-selling new and existing solutions within its existing membership base, attracting new members, building and/or acquiring new software capabilities, and realizing greater economies of scale on a primarily fixed cost base. We forecast visible, long-term annual EPS growth of 15%, compelling relative to most of the other names in our coverage universe, with low invested capital requirements.”

The Advisory Board Company closed on Thursday at $58.15.

Latest Ratings for ABCO

Nov 2015JP MorganInitiates Coverage onOverweight
Nov 2015Cantor FitzgeraldInitiates Coverage onBuy
Nov 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for ABCO
View the Latest Analyst Ratings

Posted-In: Bank of America Robert M. WilloughbyAnalyst Color Initiation Analyst Ratings


Related Articles (ABCO)

Get Benzinga's Newsletters